These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19779708)

  • 1. Female stone disease: the changing trend.
    Marickar YM; Vijay A
    Urol Res; 2009 Dec; 37(6):337-40. PubMed ID: 19779708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-Hour Urinary Chemistries and Kidney Stone Risk.
    Ferraro PM; Taylor EN; Curhan GC
    Am J Kidney Dis; 2024 Aug; 84(2):164-169. PubMed ID: 38583757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the role of urinary magnesium in calcium urolithiasis.
    Schwartz BF; Bruce J; Leslie S; Stoller ML
    J Endourol; 2001 Apr; 15(3):233-5. PubMed ID: 11339386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical risk factors for stone formation in a Scottish paediatric hospital population.
    MacDougall L; Taheri S; Crofton P
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):125-30. PubMed ID: 20144971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biochemical basis for grouping of patients with urolithiasis.
    Tiselius HG; Almgård LE; Larsson L; Sörbo B
    Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.
    Pais VM; Holmes RP; Assimos DG
    J Endourol; 2007 Feb; 21(2):232-5. PubMed ID: 17338626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and urine uric acid level may have different predictive value for urinary stone composition: a retrospective cohort study of 718 patients in Chinese population.
    Wen W; Li Y; Chen Q; Li J
    Int Urol Nephrol; 2022 Sep; 54(9):2247-2254. PubMed ID: 35089471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Yoshioka T; Koide T; Okuyama A
    Urol Res; 1998; 26(3):209-13. PubMed ID: 9694604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour urine constituents in stone formers: a study from the northeast part of Peninsular Malaysia.
    Hussein NS; Sadiq SM; Kamaliah MD; Norakmal AW; Gohar MN
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):630-7. PubMed ID: 23640651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of calcium, phosphorus, uric acid and magnesium level in serum and 24 hours urine of patients with urolithiasis.
    Gyawali PR; Joshi BR; Gurung CK
    Kathmandu Univ Med J (KUMJ); 2011; 9(34):54-6. PubMed ID: 22610870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of potassium depletion on urinary stone risk factors in Wistar rats.
    Yachantha C; Hossain RZ; Yamakawa K; Sugaya K; Tosukhowong P; Ogawa Y; Saito S
    Urol Res; 2009 Dec; 37(6):311-6. PubMed ID: 19834703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG; Ahlstrand C; Larsson L
    Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk index in urolithiasis.
    Fazil Marickar YM; Salim A
    Urol Res; 2009 Oct; 37(5):283-7. PubMed ID: 19609518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.